DK0547102T3 - Opløseliggørelse af proteiner på aktiv form - Google Patents

Opløseliggørelse af proteiner på aktiv form

Info

Publication number
DK0547102T3
DK0547102T3 DK91915661T DK91915661T DK0547102T3 DK 0547102 T3 DK0547102 T3 DK 0547102T3 DK 91915661 T DK91915661 T DK 91915661T DK 91915661 T DK91915661 T DK 91915661T DK 0547102 T3 DK0547102 T3 DK 0547102T3
Authority
DK
Denmark
Prior art keywords
protein
active form
solubilization
proteins
refolding
Prior art date
Application number
DK91915661T
Other languages
Danish (da)
English (en)
Inventor
Kumar Puri Nirdosh
Enzo Crivelli
Original Assignee
Natinco Nv
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natinco Nv, Southern Cross Biotech Pty Ltd filed Critical Natinco Nv
Application granted granted Critical
Publication of DK0547102T3 publication Critical patent/DK0547102T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91915661T 1990-09-05 1991-08-29 Opløseliggørelse af proteiner på aktiv form DK0547102T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK215990 1990-09-05
PCT/AU1991/000395 WO1992004382A1 (en) 1990-09-05 1991-08-29 Solubilization of proteins in active forms

Publications (1)

Publication Number Publication Date
DK0547102T3 true DK0547102T3 (da) 1999-04-19

Family

ID=3774938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915661T DK0547102T3 (da) 1990-09-05 1991-08-29 Opløseliggørelse af proteiner på aktiv form

Country Status (8)

Country Link
EP (1) EP0547102B1 (cg-RX-API-DMAC7.html)
AT (1) ATE168115T1 (cg-RX-API-DMAC7.html)
AU (1) AU664021B2 (cg-RX-API-DMAC7.html)
CA (1) CA2090701C (cg-RX-API-DMAC7.html)
DE (1) DE69129747T2 (cg-RX-API-DMAC7.html)
DK (1) DK0547102T3 (cg-RX-API-DMAC7.html)
ES (1) ES2119779T3 (cg-RX-API-DMAC7.html)
WO (1) WO1992004382A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1039330C (zh) * 1992-07-02 1998-07-29 皮特曼-穆尔有限公司 一种从含有无活性蛋白的溶液中回收生物活性形式重组蛋白的方法
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
US5856126A (en) * 1993-09-22 1999-01-05 Ajinomoto Co., Inc. Peptide having anti-thrombus activity and method of producing the same
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
DE10309691B4 (de) * 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
MX2011013898A (es) * 2009-06-22 2012-05-22 Amgen Inc Proteínas replegadas que usan un estado de oxido-reduccion quimicamente controlado.
EP3660032B1 (en) 2009-06-25 2025-10-22 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
ES2813501T3 (es) 2013-02-12 2021-03-24 Bristol Myers Squibb Co Métodos de replegado de proteínas basados en filtración de flujo tangencial
ES2751735T3 (es) 2013-02-12 2020-04-01 Bristol Myers Squibb Co Métodos de replegado de proteínas a elevado pH
US9982012B2 (en) 2013-03-29 2018-05-29 Dr. Reddy's Laboratories Limited Refolding of granulocyte colony stimulating factor
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
WO1986003497A1 (en) * 1984-12-06 1986-06-19 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
KR890701759A (ko) * 1987-07-29 1989-12-21 스테이너 브이. 칸스태드 에스케리키아 콜라이내에서 발현된 사람 인터루킨-4의 정제방법
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
DE3832898A1 (de) * 1988-09-28 1990-04-12 Boehringer Mannheim Gmbh Praeparat von in prokaryonten exprimiertem plasminogenaktivator
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
DE4113750A1 (de) * 1991-04-26 1992-10-29 Boehringer Mannheim Gmbh Verbesserung der renaturierung bei der sekretion von disulfidverbrueckten proteinen

Also Published As

Publication number Publication date
WO1992004382A1 (en) 1992-03-19
EP0547102A4 (cg-RX-API-DMAC7.html) 1994-04-27
AU664021B2 (en) 1995-11-02
CA2090701A1 (en) 1992-03-10
EP0547102B1 (en) 1998-07-08
DE69129747D1 (de) 1998-08-13
ES2119779T3 (es) 1998-10-16
ATE168115T1 (de) 1998-07-15
AU8403591A (en) 1992-03-30
DE69129747T2 (de) 1998-11-12
CA2090701C (en) 2000-05-16
EP0547102A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
DK322188A (da) Fremgangsmaade til fremstilling af protein
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
MX9704097A (es) Induccion de respuestas de linfocitos t citotoxicos.
ATE264691T1 (de) Newcastle-krankheitsvirus-kombinationsimpfstoff
ATE267255T1 (de) Ob proteinderivate mit verlängerter halbwertzeit
BR9915852A (pt) Conjugado de hapteno-portador para tratamento e prevenção do vìcio da nicotina
DK0538300T3 (da) O-Glycosyleret IFN-alfa
DK0429570T3 (da) Osteoinducerende præparater
DK0507933T3 (da) Nær-vaskulariserende implantationsmateriale
EE9400356A (et) Polüetüleenglükool proteiin konjugaadid, ühendid, nende kasutamine, meetod konjugaatide valmistamiseks ja ravimvormid
DK0526544T3 (da) Terapeutiske anvendelser af actinbindende forbindelser
BR9709845B1 (pt) preparaÇço aquosa de insulina, formulaÇço farmacÊutica parenteral, e, processso para aumentar a estabilidade quÍmica de uma preparaÇço de insulina.
DK0547102T3 (da) Opløseliggørelse af proteiner på aktiv form
AU7814498A (en) Multivalent (in ovo) avian vaccine
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
ATE249841T1 (de) Immunogene zubereitungen
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
DE59010164D1 (de) Wässrige Polymerisatzubereitungen
SE8700156L (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
FI944907A0 (fi) Uusi antineoplastinen sytokiini
FR2670780B1 (fr) Derives de 4-(acylamino)benzopyranes, leur preparation et leur application en therapeutique.
DE69102514D1 (de) Bestandteil eines künstlichen gliedes.
ATE265234T1 (de) Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung